Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2500-2505

  Carmina, Enrico ^a   Bucchieri, Salvo ^a   Esposito, Antonella ^b   Del Puente, Antonio ^b   Mansueto, Pasquale ^a   Orio, Francesco ^b   Di Fede, Gaetana ^a   Rini, GiovamBattista ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ABDOMINAL FAT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL MEDICINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; ITALY; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TRUNK;

EID: 34447124475     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2725     Document Type: Article

References (37)

1. Stein I, Leventhal M 1935 Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181-185
2. Goldzieher JW, Axelrod LR 1963 Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14:631-653
3. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA 2003 Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 11:2289-2293
4. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA 2006 Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2-6
5. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
6. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev 18:774-800
7. Legro RS, Kunselman AR, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607-613
8. Guzick DS 2004 Cardiovascular risk in PCOS. J Clin Endocrinol Metab 89:3694-3695
9. Carmina E, Lobo RA 2004 Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82:661-665
10. Peiris A, Sothmann M, Hoffman R, Hennes M, Wilson C, Gustafson A, Kissebah A 1989 Adiposity, fat distribution and cardiovascular risk. Ann Intern Med 110:867-872
11. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Simis EA, Poehlman ET 2001 What are the physical characteristics associated with normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86:1020-1025
12. Karelis AD, St. Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET 2004 Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-2575
13. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM 2005 Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 90:4573-4578
14. Bjontorp P 1990 Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496
15. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to metabolic syndrome. Endocr Rev 21:697-738
16. Seidell JC, Brouchard C 1997 Visceral fat in relation to health: it is a major culprit or an innocent bystander? Int J Obes 21:626-631
17. Smith SR, Lovejoy JC, Greenway F, Ryan D, DeJonge L, de la Bretonne J, Volafova J, Bray GA 2001 Contributions of total body fat, abdominal subcutaneous adipose tissue compartments and visceral adipose tissue in the metabolic components of obesity. Metabolism 50:425-435
18. Lo J, Dolan SE, Kanter JR, Hemphill LC, Connelly JM, Lees RS, Grinspoon SK 2006 Effect of obesity, body composition and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 91:1677-1682
19. Bringer J, Lefebrve P, Boulet F, Grigorescu F, Renard E, Hedon F, Orsetti A, Jaffiol C 1993 Body composition and regional fat patterning in polycystic ovarian syndrome: relationship to hormonal and metabolic profiles. Ann NY Acad Sci 687:115-123
20. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R 2002 Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883-896
21. Horejsi R, Moller R, Rackl S, Giuliani A, Reytag U, Crailsheim K, Sudi K, Tafeit E 2004 Android subcutaneous tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women. Am J Physiol Anthropol 124:275-281
22. Lord J, Thomas R, Fox B, Acharya U, Wilkin T 2006 The central issue? Visceral fat is a good marker of insulin resistance and metabolic disturbances in women with polycystic ovary syndrome. BJOG 113:1203-1209
23. Yildrim B, Sabir N, Kaleli B 2003 Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 79:1358-1364
24. Yucel A, Noyan V, Sagsoz N 2006 The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 126:81-86
25. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B 2005 Central fat excess in polycystic ovary syndrome: relation to low grade inflammation and insulin resistance. J Clin Endocrinol Metab 90:6014-6021
26. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrappa GG, Boscaro M 2004 Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 27:424-429
27. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
28. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology and management. Am J Obstet Gynecol 140:815-830
29. Lookingbill DP, Egan N, Santen RJ, Demers LM 1988 Correlation of serum 3α-androstanediol glucuronide with acne and chest hair density in men. J Clin Endocrinol Metab 67:986-991
30. Ludwig E 1977 Classification of the types of androgenic alopecia (common balding occurring in the female sex). Br J Dermatol 97:247-254
31. Carmina E 1998 Prevalence of idiopathic hirsutism. Eur J Endocrinol 139:421-423
32. Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA 2005 Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90:2545-2549
33. Katz A, Sridhar SN, Albert P 2000 Quantitative Insulin-Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
34. Lobo RA, Kletzky OA, Kaptein EM, Goebelsmann U 1980 Prolactin modulation of dehydroepiandrosterone sulfate secretion. Am J Obstet Gynecol 138:632-636
35. dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM 2005 Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and nonobese postmenopausal women. Gynecol Endocrinol 21:295-301
36. Rissanen P, Hamalainen P, Vanninen E, Tenhunen-Eskelinen M, Uusitupa M 1997 Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int J Obes Relat Metab Disord 21:367-371
37. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ 1994 Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-468